Oropharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Phase II Study of SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
Conditions: SBRT Interventions: Combination Product: SBRT+chemoimmunotherapy Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials

CompARE: study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer
DiscussionCompARE is designed to be efficient and cost-effective in response to new data, emerging new treatments or difficulties, with the aim of bringing new treatment options for these patients.Trial registrationISRCTNISRCTN41478539. Registered on 29 April 2015 (Source: Trials)
Source: Trials - January 15, 2024 Category: Research Source Type: clinical trials

Validity of Viome's Oral/Throat Cancer Test
Conditions: Oral and Throat Cancer; Oropharyngeal Squamous Cell Carcinoma; Oral Squamous Cell Carcinoma Interventions: Device: Oral/Throat cancer test Sponsors: Viome Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials

Phase II Randomized-registry Embedded Study of Lymphoscintigraphy for Oropharyngeal Neoplasms to Enable Risk-adapted Nodal Guidance for Robotic Surgery and/or Radiotherapy (LONE-RANGR2)
Conditions: Oropharyngeal Neoplasms; Robotic Surgery and/or Radiotherapy; Lymphoscintigraphy Interventions: Radiation: Arm 1- Ipsilateral Sponsors: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials

PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
Conditions: Oropharyngeal Cancer Interventions: Procedure: Toxicities reduced treatment; Procedure: Conventional treatment Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials

A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
Conditions: Oropharyngeal Squamous Cell Carcinoma Sponsors: Centro di Riferimento Oncologico - Aviano Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain
Conditions: Pulsed Radiofrequency; Super Voltage Pulsed Radiofrequency; Glossopharyngeal Nerve; Oropharyngeal Cancer; Pain Interventions: Procedure: Supervoltage pulsed radiofrequency glossopharyngeal nerve block; Procedure: Standard voltage pulsed radiofrequency glossopharyngeal nerve block Sponsors: National Cancer Institute, Egypt Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials

Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study
Conditions: Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma Interventions: Other: Non-Interventional Study Sponsors: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials

Prospective Clinical Study to Assess the Safety and Efficacy of Versius, in Transoral Robotic Surgery
Conditions: Squamous Cell Carcinoma of the Oropharynx; Squamous Cell Carcinoma, Unknown Primary Interventions: Device: Versius Surgical System Sponsors: CMR Surgical Ltd; Liverpool University Hospitals NHS Foundation Trust; Sintesi Research S.r.l. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 1, 2023 Category: Research Source Type: clinical trials

Real-time Targeted Fluorescence Endoscopy for Detection of the Primary Cancer Lesion in Patients With a Metastasis of Unknown Primary Tumor in the Head and Neck
Conditions: Unknown Primary Tumors; Oropharynx Cancer Interventions: Diagnostic Test: Detection of lesions using fluorescence molecular imaging Sponsors: University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer
Conditions: PREDICTIVE BIOMARKERS; Evaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPC; HPV 16 Positive Oropharyngeal Tumors (OPC) Interventions: Diagnostic Test: HPV-ASSOCIATED OROPHARYNGEAL CANCER Sponsors: Regina Elena Cancer Institute; University of California, San Diego; Lega Italiana per la Lotta contro i Tumori Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 24, 2023 Category: Research Source Type: clinical trials

Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Conditions: Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Oropharynx Cancer; Oropharynx Squamous Cell Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma Interventions: Other: Experimental Observation; Other: Observation per Standard of Care; Radiation: Adjuvant Treatment per Standard of Care; Diagnostic Test: Circulating Tumor DNA test (ctDNA test) Sponsors: University of Maryland, Baltimore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2023 Category: Research Source Type: clinical trials

A Window of Opportunity Study of Black Raspberry for Patients With HNSCC
Conditions: Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Interventions: Drug: Black Raspberry Sponsors: Mitchell Machtay Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Testing the Addition of an Investigational Drug, Xevinapant, to Usual Radiation Therapy Plus Cisplatin/Carboplatin for Patients With Head and Neck Cancer
Conditions: Head and Neck Squamous Cell Carcinoma; Hypopharyngeal Squamous Cell Carcinoma; Laryngeal Squamous Cell Carcinoma; Oral Cavity Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma; Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8; Stage III Hypopharyngeal Carcinoma AJCC v8; Stage III Laryngeal Cancer AJCC v8; Stage III Lip and Oral Cavity Cancer AJCC v8; Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8; Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8; Stage IV Hypopharyngeal Carcinoma AJCC v8; Stage IV Laryngeal Cancer AJCC v8; Stage IV Lip and Or...
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials

The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
Conditions: Hypoxia; Gastric Polyp; Colon Cancer; Esophageal Cancer Interventions: Device: the COMBO Endoscopy Oropharyngeal Airway; Device: Regular Nasal Cannula Sponsors: RenJi Hospital; Tianjin Medical University General Hospital; The First Affiliated Hospital with Nanjing Medical University; First Affiliated Hospital Xi ' an Jiaotong University; Qianfoshan Hospital; Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials